13F Notebook
← Dashboard
Fund detail

Baillie Gifford

large-active, growth, lo

Quarters 52
2022-12-31 $95.96B
Positions 488
Showing 13 of 13 rows (filtered from 501)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 Avalara Inc $0 0 -4,975 -100.00% 0.00%
2 BridgeBio Pharma Inc $0 0 -499,889 -100.00% 0.01%
3 CH Robinson Worldwide $0 0 -626,161 -100.00% 0.06%
4 Coherent Corp $0 0 -477 -100.00% 0.00%
5 Duke Realty Corporation REIT $0 0 -300,000 -100.00% 0.01%
6 Global Blood Therapeutics Inc $0 0 -892 -100.00% 0.00%
7 Ivanhoe Mines $0 0 -1,400 -100.00% 0.00%
8 Li Auto ADR $0 0 -5,825,186 -100.00% 0.14%
9 NV5 Global $0 0 -155 -100.00% 0.00%
10 Stryker $0 0 -47 -100.00% 0.00%
11 Trip.com Group Sponsored ADR $0 0 -790,970 -100.00% 0.02%
12 Unity Biotechnology Inc $0 0 -589,111 -100.00% 0.00%
13 Zymergen Inc $0 0 -2,821,956 -100.00% 0.01%